KIF11 and neoplasm: The ability of docetaxel to kill tumor cells independent of its effects on mitosis could have important implications for the use and development of mitosis-specific drugs, such as Eg5 or Aurora A inhibitors (reviewed in [40]) and might explain the marginal anti-tumor effects of these drugs in patients until now [41], [42].